WXWH0226

N/A

Report date: 2022/09/13 16:04:46
NME

Base Information

Drug NameWXWH0226
Drug Alias NameWXWH0226WXWH-0226
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLeucine-rich repeat serine/threonine-protein kinase 2 inhibitors
TargetsLeucine-rich repeat serine/threonine-protein kinase 2
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesGuizhou Inochini Technology Co LtdWuxi Apptec Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesGuizhou Inochini Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A